1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow Cellerys AG: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Peptide-coupled Red Blood Cells for the Treatment of Multiple Sclerosis CLS12311 low, CLS12311 medium, CLS12311 high - Relapsing-remitting Multiple Sclerosis (RRMS) | Phase 1 | Completed | Cellerys AG | 11 | 2024-06-18 | 2026-06-08 |
Multiple Sclerosis, Relapsing-Remitting (1)
Czechia (1) · Germany (1) · Italy (1) · Switzerland (1)